These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 2502468)

  • 1. Comparative induction of drug-metabolizing enzymes by hypolipidaemic compounds.
    Boiteux-Antoine AF; Magdalou J; Fournel-Gigleux S; Siest G
    Gen Pharmacol; 1989; 20(4):407-12. PubMed ID: 2502468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of hypolipidemic compounds on lauric acid hydroxylation and phase II enzymes.
    Thomas H; Schladt L; Knehr M; Post K; Oesch F; Boiteux-Antoine AF; Fournel-Gigleux S; Magdalou J; Siest G
    Biochem Pharmacol; 1989 Jun; 38(12):1963-9. PubMed ID: 2500933
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of 1-benzylimidazole on cytochromes P-450 induction and on the activities of epoxide hydrolases and UDP-glucuronosyltransferases in rat liver.
    Magdalou J; Totis M; Boiteux-Antoine AF; Fournel-Gigleux S; Siest G; Schladt L; Oesch F
    Biochem Pharmacol; 1988 Sep; 37(17):3297-304. PubMed ID: 2840913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study of four hypolipidaemic agents on the activity of drug-metabolizing enzymes in rat liver microsomes.
    Fournel S; Magdalou J; Batt AM; Siest G
    Int J Clin Pharmacol Res; 1983; 3(6):431-6. PubMed ID: 6432712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of distinct forms of cytochromes P-450, epoxide metabolizing enzymes and UDP-glucuronosyltransferases in rat skin.
    Pham MA; Magdalou J; Totis M; Fournel-Gigleux S; Siest G; Hammock BD
    Biochem Pharmacol; 1989 Jul; 38(13):2187-94. PubMed ID: 2500129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Concomitant induction of cytosolic but not microsomal epoxide hydrolase with peroxisomal beta-oxidation by various hypolipidemic compounds.
    Schladt L; Hartmann R; Timms C; Strolin-Benedetti M; Dostert P; Wörner W; Oesch F
    Biochem Pharmacol; 1987 Feb; 36(3):345-51. PubMed ID: 2880593
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microsomal and cytosolic epoxide hydrolases, the peroxisomal fatty acid beta-oxidation system and catalase. Activities, distribution and induction in rat liver parenchymal and non-parenchymal cells.
    Steinberg P; Schladt L; Dienes HP; Timms C; Oesch F
    Eur J Biochem; 1988 Sep; 176(1):39-45. PubMed ID: 3416872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunochemical study on the contribution of hypolipidaemic-induced cytochrome P-452 to the metabolism of lauric acid and arachidonic acid.
    Bains SK; Gardiner SM; Mannweiler K; Gillett D; Gibson GG
    Biochem Pharmacol; 1985 Sep; 34(18):3221-9. PubMed ID: 3929789
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selective induction of rat liver phase II enzymes by N-heterocycle analogues of phenanthrene: a response exhibiting high correlation between UDP-glucuronosyltransferase and microsomal epoxide hydrolase activities.
    Franklin MR; Slawson MH; Moody DE
    Xenobiotica; 1993 Mar; 23(3):267-77. PubMed ID: 8498089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential induction profile of drug-metabolizing enzymes after treatment with hypolipidaemic agents.
    Fournel S; Magdalou J; Pinon P; Siest G
    Xenobiotica; 1987 Apr; 17(4):445-57. PubMed ID: 2885979
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential induction of cytosolic epoxide hydrolase, microsomal epoxide hydrolase, and glutathione S-transferase activities.
    Hammock BD; Ota K
    Toxicol Appl Pharmacol; 1983 Nov; 71(2):254-65. PubMed ID: 6636190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatic levels of cytosolic, microsomal and 'mitochondrial' epoxide hydrolases and other drug-metabolizing enzymes after treatment of mice with various xenobiotics and endogenous compounds.
    Meijer J; DePierre JW
    Chem Biol Interact; 1987; 62(3):249-69. PubMed ID: 3621371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distribution and inducibility of cytosolic epoxide hydrolase in male Sprague-Dawley rats.
    Schladt L; Wörner W; Setiabudi F; Oesch F
    Biochem Pharmacol; 1986 Oct; 35(19):3309-16. PubMed ID: 3768023
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of hypolipidemic agents on the hepatic microsomal drug-metabolizing enzyme system of the rat. Induction of cytochrome(s) P-450 with specificity toward terminal hydroxylation of lauric acid.
    Orton TC; Parker GL
    Drug Metab Dispos; 1982; 10(2):110-5. PubMed ID: 6124394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective induction of phase II drug metabolizing enzyme activities by quinolines and isoquinolines.
    Le HT; Franklin MR
    Chem Biol Interact; 1997 Mar; 103(3):167-78. PubMed ID: 9134007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure-dependent induction of bilirubin glucuronidation and lauric acid 12-hydroxylation by arylcarboxylic acids chemically related to clofibrate.
    Fournel S; Magdalou J; Thomassin J; Villoutreix J; Siest G; Caldwell J; André JC
    Biochim Biophys Acta; 1985 Oct; 842(2-3):202-13. PubMed ID: 3931693
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Rat cytosolic epoxide hydrolase.
    Oesch F; Schladt L; Hartmann R; Timms C; Wörner W
    Adv Exp Med Biol; 1986; 197():195-201. PubMed ID: 3766258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential action of thyroid hormones and chemically related compounds on the activity of UDP-glucuronosyltransferases and cytochrome P-450 isozymes in rat liver.
    Goudonnet H; Magdalou J; Mounie J; Naoumi A; Viriot ML; Escousse A; Siest G; Truchot R
    Biochim Biophys Acta; 1990 Jul; 1035(1):12-9. PubMed ID: 2116906
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-benzylimidazole, a high magnitude inducer of rat hepatic cytochrome P-450 exhibiting both polycyclic aromatic hydrocarbon- and phenobarbital-type induction of phase I and phase II drug-metabolizing enzymes.
    Papac DI; Franklin MR
    Drug Metab Dispos; 1988; 16(2):259-64. PubMed ID: 2898344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of the drug-metabolizing enzymes.
    Poland A
    IARC Sci Publ; 1982; (39):351-64. PubMed ID: 6818143
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.